Research Interests
Our goal is to bridge the gap between the study of brain as a computational device and the search for novel neuropathological treatments. We develop technologies to manipulate molecules, cells, and synapses in the brain, and deploy these reagents in mouse models of disease.
Selected Grants
Neurobiology Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029The role of dystrophin in synapse development.
ResearchPrincipal Investigator · Awarded by University of Texas Health Science Center at San Antonio · 2024 - 2028DART.3-Revolutionizing Neuropsychiatric Treatment through Noninvasive, Programmable Cell-Type-Specific Neuropharmacology
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2027University Training Program in Biomolecular and Tissue Engineering
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1994 - 2027Unmasking neuromodulatory control of locomotion
ResearchPrincipal Investigator · Awarded by Washington University in St. Louis · 2024 - 2027CIRCUIT MECHANISMS FOR DOPAMINE NEURON VULNERABILITY AND RESILIENCE IN PD - Extension
ResearchCo Investigator · Awarded by Michael J. Fox Foundation for Parkinson's Research · 2021 - 2026Neuroactive steroids as novel psychiatric treatments: mechanistic studies
ResearchPrincipal Investigator · Awarded by Washington University in St. Louis · 2021 - 2026Interrogating the cholinergic basis of opioid reinforcement with subcellular precision
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2026High-resolution measurement of natural stimuli and ethologically relevant behavior as platform for understanding the nervous system
ResearchCo-Principal Investigator · Awarded by National Institute on Drug Abuse · 2024 - 2026Parvalbumin interneurons regulate nucleus accumbens synapses and behavior
ResearchPrincipal Investigator · Awarded by Vanderbilt University Medical Center · 2021 - 2025Cerebellar pathology in the absence of plasticity gating
ResearchPrincipal Investigator · Awarded by University of Texas Health Science Center at San Antonio · 2021 - 2025GRIP Display NCBioTech
ResearchPrincipal Investigator · Awarded by North Carolina Biotechnology Center · 2023 - 2025Combating obesity via cell-specific pharmacology of dopamine neurons
FellowshipPrincipal Investigator · Awarded by American Heart Association · 2023 - 2024Evaluating cell type-specific non-dopaminergics as a Parkinson's treatment paradigm
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2024Striatal Microcircuit Drivers of Adaptive Learning in Habit Formation
ResearchCo Investigator · Awarded by National Institutes of Health · 2018 - 2023Interrogating dynamics of whole-brain volumes with cell type-specific pharmacology
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2023Receptive field coordination across mosaics of diverse retinal ganglion cell types in the mammalian retina
ResearchCollaborator · Awarded by National Institutes of Health · 2020 - 2022DART2.0: comprehensive cell type-specific behavioral neuropharmacology
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2022Significance of excitatory and inhibitory synaptic integration by interneurons for local circuit dynamics and behavior
FellowshipCo-Sponsor · Awarded by National Institutes of Health · 2020 - 2021Deconstructing the Behavioral Neuropharmacology of Parkinson's Disease
ResearchPrincipal Investigator · Awarded by Parkinson's Disease Foundation · 2017 - 2020Interrogating brain dynamics with cell type-specific pharmacology
ResearchPrincipal Investigator · Awarded by Whitehall Foundation, Inc. · 2018 - 2019External Relationships
- MICHAEL J FOX / ASAP
- Tufts University
- University of Colorado ¿ Anschutz Medical Campus
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.